The effect of CWI on blood levels of (A) thyroid-stimulating hormone (TSH) and (B) testosterone in young healthy males. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of CK, CK-MB and LDH before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of liver profile parameters before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of renal profile parameters before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of hormonal parameters before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of electrolyte concentrations before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of lipid profile parameters before and after CWI. by Aneta Teległów (9570190)

Subjects:

The effect of CWI on blood levels of (A) creatine kinase (CK); (B) CK-muscle brain (CK-MB) and (C) lactate dehydrogenase (LDH) in young healthy males. by Aneta Teległów (9570190)

Subjects:

<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate.... by Atefeh Sadeghi (21253051)

“…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”

No significant differences in the numbers of eggs between Mst1^+/+ and Mst1^ΔM/ΔM mice. by Jianyang Li (461703)

Utilization of anticoagulants at eight hospitals from 2019 to 2023. by Wei Luo (80175)

Subjects:

Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

Indications for warfarin prescription in outpatients and inpatients in 2023. by Wei Luo (80175)

Subjects:

Outpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

DDC for four anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

Utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

The expenditure on anticoagulants in the period of 2019-2023(million CNY). by Wei Luo (80175)

Subjects:

Regression estimates and incidence rate ratios from GLMER for number of papers (top) and coauthors (bottom). by William C. Barley (8915282)

Subjects:

Differences in mean number of papers (top) and co-authors (bottom) depending on (1) NI membership and (2) time joined NI. by William C. Barley (8915282)

Subjects:

Correlation between relative amounts of lipid species and number of days since the onset of symptoms among COVID-19 cases. by Spela Kokelj (8356644)

Subjects: